Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05203913
Title Home Search Results Study Record Detail Save this study Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer (CNN-BC)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Indications

bladder urothelial carcinoma

Therapies

Cisplatin + Nab-paclitaxel + Nivolumab

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.